Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene
Congenital amegakaryocytic thrombocytopenia (CAMT) generally begins at birth with severe thrombocytopenia and progresses to pancytopenia. It is caused by mutations in the thrombopoietin receptor gene, the myeloproliferative leukemia virus oncogene (c-MPL). The association between CAMT and c-MPL muta...
Main Authors: | İkbal Ok Bozkaya, Neşe Yaralı, Pamir Işık, Rukiye Ünsal Saç, Betül Tavil, Bahattin Tunç |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-05-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-22220 |
Similar Items
-
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2017-11-01) -
Non-myeloablative conditioning is sufficient to achieve complete donor myeloid chimerism following matched sibling donor bone marrow transplant for myeloproliferative leukemia virus oncogene (MPL) mutation-driven congenital amegakaryocytic thrombocytopenia: Case report
by: Joseph Hai Oved, et al.
Published: (2022-07-01) -
MPL Y252H and MPL F126fs mutations in essential thrombocythemia: Case series and review of literature
by: Ahmed G. Elsayed, et al.
Published: (2019-03-01) -
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
by: Isabelle Plo, et al.
Published: (2017-09-01) -
Clinical and molecular characteristics of acute myeloid leukemia with MPL mutation
by: Yu Chen, et al.
Published: (2022-12-01)